**Core Concept**
In the second trimester, ultrasound markers are used to assess the risk of Down's syndrome, a genetic disorder caused by an extra copy of chromosome 21. These markers include nuchal translucency, nasal bone absence, and ductus venosus flow abnormalities, among others.
**Why the Correct Answer is Right**
Ultrasound markers for Down's syndrome in the second trimester include:
- Nuchal translucency (NT) thickness > 3.5 mm, indicating an increased risk of aneuploidy.
- Absence of the nasal bone, which is a soft tissue marker that can be associated with Down's syndrome.
- Ductus venosus flow abnormalities, such as reversed or absent flow, which can indicate an increased risk of cardiac anomalies and Down's syndrome.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is not a marker of Down's syndrome. However, without knowing the actual options, it is difficult to provide a specific explanation.
**Option B:** This option is incorrect because it is not a recognized marker of Down's syndrome. However, without knowing the actual options, it is difficult to provide a specific explanation.
**Option C:** This option is incorrect because it is not a marker of Down's syndrome. However, without knowing the actual options, it is difficult to provide a specific explanation.
**Option D:** This option is incorrect because it is not a marker of Down's syndrome. However, without knowing the actual options, it is difficult to provide a specific explanation.
**Clinical Pearl / High-Yield Fact**
When interpreting second-trimester ultrasound markers, it's essential to remember that a single abnormal marker does not necessarily confirm Down's syndrome. A combination of markers and maternal age should be considered when assessing the risk.
**Correct Answer:** Not enough information to provide a correct answer. Please provide the actual options.
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.